Home NEWS Coronavirus: Oxford University vaccine trial paused after participant falls ill

Coronavirus: Oxford University vaccine trial paused after participant falls ill

2 min read
0
79

Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse reaction in the UK.

AstraZeneca described it as a “routine” pause in the case of “an unexplained illness”.

The outcome of vaccine trials is being closely watched around the world.

The AstraZeneca-Oxford University vaccine is seen as a strong contender among dozens being developed globally.

Hopes have been high that the vaccine might be one of the first to come on the market, following successful phase 1 and 2 testing.

Its move to Phase 3 testing in recent weeks has involved some 30,000 participants in the US as well as in the UK, Brazil and South Africa. Phase 3 trials in vaccines often involve thousands of participants and can last several years.

The New York Times is reporting a volunteer in the UK trial has been diagnosed with transverse myelitis, an inflammatory syndrome that affects the spinal cord and can be caused by viral infections.

However, the cause of the illness has not been confirmed and an independent investigation will now work out if there was any link to the vaccine.

 

Source: graphic.com.gh

0
Please leave a feedback on thisx
Load More Related Articles
Load More By King Mark
Load More In NEWS
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

Check Also

Scrapping of levies in price build-up could compromise the quality of fuel at the pumps – NPA

Communications Manager at the National Petroleum Authority, Mohammed Abdul Kudus has expla…